Osmetech Molecular Diagnostics

757 S. Raymond Avenue
91731 Pasadena, CA

Phone: +1 626 463-2000
Fax: +1 626 463-2012


Company Profile

About us
Osmetech plc is an AIM-listed public company on the London Stock Exchange under ticker symbol OMH. Osmetech plc is incorporated in England and Wales and its main country of operations is the US.

Osmetech plc was founded in 1993, developing electronic odour sensor (“e-nose”) technology. IPO followed in 1994 and in 1999, the Company changed its name from Aromascan to Osmetech refocusing the business on the opportunities within the global healthcare market. With the acquisition of the OPTI (blood gas) product line from Roche Diagnostics in 2003, the Critical Care Diagnostic Division was formed, which more than doubled its level of sales revenues in 3 years through a strong network of international distributors.

The Osmetech Molecular Diagnostics division was created from acquisitions of Molecular Sensing plc in October 2004 and Clinical Micro Sensors, Inc. from Motorola in July 2005. Recently, Osmetech divested its Critical Care Diagnostic Division and is now focused on accelerating the expansion and development of the Molecular Diagnostic Division.

OSM Gesellschaft für offene Systeme in der Medizin mbH
Oscimed S.A.
Osborn Somepic Technologie
OSATU, S. Coop.

Osteometer MediTech, Inc.
Osteosys Co., Ltd.
Osyris Medical
Otto Suhner AG